Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Antibody Stories

2013-08-13 08:29:26

TSX: AMF TORONTO, Aug. 13, 2013 /CNW/ - Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the three months ended June 30, 2013. "Through strategic collaborations and partnerships as well as our own internal research efforts, we continue to advance our diagnostics and therapeutic antibody programs", said Dr. Robert Gundel, Amorfix President and...

Ancient Immune Cells In Lampreys Similar To Ours, But More Complex
2013-08-13 08:06:38

April Flowers for redOrbit.com - Your Universe Online When biologists study lampreys, they are able to envision the evolutionary past because these jawless specimens represent an early offshoot to the evolutionary tree, before sharks and fish. They have an inconspicuous appearance, but a sophisticated immune system with three types of white blood cells that resemble our B and T cells. A new study from Emory University School of Medicine and the Max Planck Institute of Immunology and...

2013-08-07 16:28:09

TARRYTOWN, N.Y., Aug. 7, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the United States Patent and Trademark Office granted U.S. Patent No. 8,502,018 relating to methods of genetically modifying a mouse to make human antibodies. A similar European patent, EP 1 360 287 B1, was granted by the European Patent Office on September 12, 2012. These patents form part of Regeneron's global patent portfolio, which together protect fundamental...

2013-08-06 04:21:26

BREDA, The Netherlands, August 6, 2013 /PRNewswire/ -- Meeting The Increasing Demand For Technologies That Enable Antibody Product Differentiation arGEN-X, a clinical stage biopharmaceutical company specialized in the creation and development of highly differentiated human antibody therapeutics, today announces the signing of its second non-exclusive license agreement for its antibody half-life extension technology,...

2013-08-02 12:34:23

Weill Cornell scientists reveal how the protein works and how the drug gums it up, offering new hope for treatment of aggressive cancer Researchers have discovered how an experimental drug is capable of completely eradicating human lymphoma in mice after just five doses. The study, led by researchers at Weill Cornell Medical College, sets the stage for testing the drug in clinical trials of diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin lymphoma, itself the...

Sugar-based Detection Method Enables Easy And Accurate Identification Of The Yersinia Pestis Bacterium
2013-07-24 15:00:29

Max Planck Institute Diagnosing the presence of Yersinia pestis, the cause of plague, may soon be easier than ever before. Scientists working with Peter Seeberger, Director at the Max Planck Institute of Colloids and Interfaces (MPIKG) in Potsdam and Professor at the Freie Universitat Berlin, have come up with a simple, inexpensive and reliable method of detecting the bacterium. The research team, specializing in glycochemistry glycobiology, first identified and synthesized an...

2013-07-18 12:27:34

New Funding Advances Mission to Provide Flow Cytometry Users with a Solution to the 'Missing Color' Problem and for Strategic Partners a Means to Supply Antibodies with Unlimited User-Labeling Options SAN DIEGO, July 18, 2013 /PRNewswire/ -- Solulink, Inc., an emerging life science tools company with expertise in biomolecular linking, today announced the completion of a new round of equity financing. The funds will enable Solulink to accelerate the commercialization of its HybriLink...

2013-07-09 17:22:06

Researchers identify risk factor for autism in a subset of children: Maternal antibody-related autism UC Davis MIND Institute researchers have identified the specific antibodies that target fetal brain proteins in the blood of a subset of women whose children are diagnosed with autism. The finding is the first to pinpoint a specific risk factor for a significant subset of autism cases, as well as a biomarker for drug development and early diagnosis. The researchers have named autism...

2013-07-02 08:26:38

MONROVIA, Calif., July 2, 2013 /PRNewswire/ -- Xencor, Inc. announced today that that it has entered into a technology license and option agreement to provide Merck, known as MSD outside the United States and Canada, access to one of Xencor's Fc engineering patents for a therapeutic monoclonal antibody. Under the agreement, Merck will be granted a non-exclusive license to a Xencor patent for use in an undisclosed product, as well as an option to license the same intellectual property...

2013-07-01 15:04:38

A team led by scientists at The Scripps Research Institute (TSRI) has identified a family of tiny RNA molecules that work as powerful regulators of the immune response in mammals. Mice who lack these RNA molecules lose their normal infection-fighting ability, whereas mice that overproduce them develop a fatal autoimmune syndrome. "This finding gives us insights into immune regulation that could be very helpful in a range of medical applications, from viral vaccines to treatments for...